Literature DB >> 10103213

Sequences of the genes for the TEM-20, TEM-21, TEM-22, and TEM-29 extended-spectrum beta-lactamases.

G Arlet1, S Goussard, P Courvalin, A Philippon.   

Abstract

The sequences of the blaTEM genes encoding TEM-20, TEM-21, TEM-22, and TEM-29 extended-spectrum beta-lactamases were determined. Analysis of the deduced amino acid sequences indicated that TEM-20 and TEM-29 were derived from TEM-1 and that TEM-21 and TEM-22 were derived from TEM-2. The substitutions involved were Ser-238 and Thr-182 for TEM-20; His-164 for TEM-29; Lys-104, Arg-153, and Ser-238 for TEM-21; and Lys-104, Gly-237, and Ser-238 for TEM-22. The promoter region of the blaTEM-22 gene was identical to that of blaTEM-3. High-level production of TEM-20 could result from a 135-bp deletion which combined the -35 region of the Pa promoter with the -10 region of the P3 promoter and a G-->T transition in the latter motif.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10103213      PMCID: PMC89239     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Substrate specificities in class A beta-lactamases: preference for penams vs. cephems. The role of residue 237.

Authors:  W J Healey; M R Labgold; J H Richards
Journal:  Proteins       Date:  1989

3.  Two novel transferable extended-spectrum beta-lactamases from Klebsiella pneumoniae in Tunisia.

Authors:  S Ben Redjeb; G Fournier; C Mabilat; A Ben Hassen; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1990-01-15       Impact factor: 2.742

4.  Two improved promoter sequences for the beta-lactamase expression arising from a single base-pair substitution.

Authors:  S T Chen; R C Clowes
Journal:  Nucleic Acids Res       Date:  1984-04-11       Impact factor: 16.971

5.  Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.

Authors:  D Sirot; J Sirot; R Labia; A Morand; P Courvalin; A Darfeuille-Michaud; R Perroux; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

6.  Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum beta-lactamases TEM-4 and TEM-5 in enterobacteriaceae.

Authors:  W Sougakoff; A Petit; S Goussard; D Sirot; A Bure; P Courvalin
Journal:  Gene       Date:  1989-05-30       Impact factor: 3.688

7.  Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.

Authors:  A Vuye; G Verschraegen; G Claeys
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

8.  Molecular characterization of a TEM-21 beta-lactamase in a clinical isolate of Morganella morganii.

Authors:  F Tessier; C Arpin; A Allery; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.

Authors:  G C Paul; G Gerbaud; A Bure; A M Philippon; B Pangon; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

View more
  19 in total

1.  SHV-14, a novel beta-lactamase variant in Klebsiella pneumoniae isolates from Nijmegen, The Netherlands.

Authors:  M Yuan; L M Hall; J Hoogkamp-Korstanje; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates.

Authors:  C de Champs; C Monne; R Bonnet; W Sougakoff; D Sirot; C Chanal; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolate.

Authors:  C Neuwirth; R Labia; E Siebor; A Pechinot; S Madec; E B Chaibi; A Kazmierczak
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Resistance to beta-lactamase inhibitor protein does not parallel resistance to clavulanic acid in TEM beta-lactamase mutants.

Authors:  William A Schroeder; Troy R Locke; Susan E Jensen
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.

Authors:  Makoto Ohnishi; Emi Ono; Ken Shimuta; Haruo Watanabe; Noboru Okamura
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

6.  CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection.

Authors:  Frédéric Robin; Julien Delmas; Maryse Archambaud; Cédric Schweitzer; Catherine Chanal; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

7.  Low-virulence Citrobacter species encode resistance to multiple antimicrobials.

Authors:  C Pepperell; J V Kus; M A Gardam; A Humar; L L Burrows
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

8.  Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital.

Authors:  C Chanal; R Bonnet; C De Champs; D Sirot; R Labia; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

9.  Identifying antimicrobial resistance genes with DNA microarrays.

Authors:  Douglas R Call; Marlene K Bakko; Melissa J Krug; Marilyn C Roberts
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Successive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital.

Authors:  M Biendo; B Canarelli; D Thomas; F Rousseau; F Hamdad; C Adjide; G Laurans; F Eb
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.